[Bevacizumab-induced abdominal aortic thrombosis].
Védrine
Lionel
L
Service d'oncologie et radiothérapie, Hôpital d'instruction des armées du Val-de-Grâce, F-75005 Paris, France. lionelvedrine@orange.fr
Chargari
Cyrus
C
D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001012:Aorta, Abdominal; D001018:Aortic Diseases / Q000139:chemically induced*; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D013927:Thrombosis / Q000139:chemically induced*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab